248 related articles for article (PubMed ID: 15602499)
1. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
Mathias S; Zihl J; Steiger A; Lancel M
Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
[TBL] [Abstract][Full Text] [Related]
2. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
[TBL] [Abstract][Full Text] [Related]
3. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
5. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia.
Deacon S; Staner L; Staner C; Legters A; Loft H; Lundahl J
Sleep; 2007 Mar; 30(3):281-7. PubMed ID: 17425224
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia.
Lundahl J; Staner L; Staner C; Loft H; Deacon S
Psychopharmacology (Berl); 2007 Nov; 195(1):139-46. PubMed ID: 17653697
[TBL] [Abstract][Full Text] [Related]
7. Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia.
Dijk DJ; Stanley N; Lundahl J; Groeger JA; Legters A; Trap Huusom AK; Deacon S
J Psychopharmacol; 2012 Aug; 26(8):1096-107. PubMed ID: 22002961
[TBL] [Abstract][Full Text] [Related]
8. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
Lankford DA; Corser BC; Zheng YP; Li Z; Snavely DB; Lines CR; Deacon S
Sleep; 2008 Oct; 31(10):1359-70. PubMed ID: 18853933
[TBL] [Abstract][Full Text] [Related]
9. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
10. The GABA(A) agonist gaboxadol improves the quality of post-nap sleep.
Mathias S; Steiger A; Lancel M
Psychopharmacology (Berl); 2001 Sep; 157(3):299-304. PubMed ID: 11605086
[TBL] [Abstract][Full Text] [Related]
11. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
Walsh JK; Deacon S; Dijk DJ; Lundahl J
Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
[TBL] [Abstract][Full Text] [Related]
12. Effect of the GABAA agonist gaboxadol on nocturnal sleep and hormone secretion in healthy elderly subjects.
Lancel M; Wetter TC; Steiger A; Mathias S
Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E130-7. PubMed ID: 11404230
[TBL] [Abstract][Full Text] [Related]
13. EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia.
Lundahl J; Deacon S; Maurice D; Staner L
J Psychopharmacol; 2012 Aug; 26(8):1081-7. PubMed ID: 22057018
[TBL] [Abstract][Full Text] [Related]
14. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
15. The effect of placebo administration on the first-night effect in healthy young volunteers.
Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
[TBL] [Abstract][Full Text] [Related]
16. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
[TBL] [Abstract][Full Text] [Related]
17. Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.
Boyle J; Danjou P; Alexander R; Calder N; Gargano C; Agrawal N; Fu I; McCrea JB; Murphy MG
Br J Clin Pharmacol; 2009 Feb; 67(2):180-90. PubMed ID: 19094161
[TBL] [Abstract][Full Text] [Related]
18. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
19. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
20. Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies.
Roth T; Lines C; Vandormael K; Ceesay P; Anderson D; Snavely D
J Clin Sleep Med; 2010 Feb; 6(1):30-9. PubMed ID: 20191935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
